Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Robin Ganellin

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 4, 2002
Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonistsSven Grassmann, Bassem Sadek, Xavier Ligneau, et al.
Journal of Medicinal Chemistry|August 23, 2002
Influence of bulky substituents on histamine h(3) receptor agonist/antagonist propertiesAstrid Sasse, Xavier Ligneau, Agnès Rouleau, et al.
Archiv Der Pharmazie|October 12, 2004
Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivativesSven Grassmann, Joachim Apelt, Xavier Ligneau, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2008
Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR)Bhaskar C Das, Ankanahlli V Madhukumar, Jaime Anguiano, et al.
Journal of Medicinal Chemistry|April 30, 2004
4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonistsGalina Meier, Michael Krause, Annette Hüls, et al.
Archiv Der Pharmazie|September 26, 2008
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonistsNicolas Levoin, Thierry Calmels, Olivia Poupardin-Olivier, et al.
Journal of Medicinal Chemistry|May 28, 2004
Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chainNadia Pelloux-Léon, Abdellatif Fkyerat, Antonia Piripitsi, et al.
Bioorganic & Medicinal Chemistry|April 26, 2003
Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinitiesSven Grassmann, Joachim Apelt, Wolfgang Sippl, et al.
Journal of Medicinal Chemistry|November 11, 2005
Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitorsC Robin Ganellin, Paul B Bishop, Ramesh B Bambal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Protean agonism at histamine H3 receptors in vitro and in vivoFlorence Gbahou, Agnès Rouleau, Séverine Morisset, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 4, 2002
Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonistsSven Grassmann, Bassem Sadek, Xavier Ligneau, et al.
Journal of Medicinal Chemistry|August 23, 2002
Influence of bulky substituents on histamine h(3) receptor agonist/antagonist propertiesAstrid Sasse, Xavier Ligneau, Agnès Rouleau, et al.
Archiv Der Pharmazie|October 12, 2004
Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivativesSven Grassmann, Joachim Apelt, Xavier Ligneau, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2008
Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR)Bhaskar C Das, Ankanahlli V Madhukumar, Jaime Anguiano, et al.
Journal of Medicinal Chemistry|April 30, 2004
4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonistsGalina Meier, Michael Krause, Annette Hüls, et al.
Archiv Der Pharmazie|September 26, 2008
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonistsNicolas Levoin, Thierry Calmels, Olivia Poupardin-Olivier, et al.
Journal of Medicinal Chemistry|May 28, 2004
Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chainNadia Pelloux-Léon, Abdellatif Fkyerat, Antonia Piripitsi, et al.
Bioorganic & Medicinal Chemistry|April 26, 2003
Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinitiesSven Grassmann, Joachim Apelt, Wolfgang Sippl, et al.
Journal of Medicinal Chemistry|November 11, 2005
Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitorsC Robin Ganellin, Paul B Bishop, Ramesh B Bambal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Protean agonism at histamine H3 receptors in vitro and in vivoFlorence Gbahou, Agnès Rouleau, Séverine Morisset, et al.
Pageof 3